Us Nuclear Financials
This page shows Us Nuclear (UCLE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Improving product-level margins are being offset by thin liquidity and externally funded losses, leaving the business short of self-funding.
FY2024’s smaller net loss did not translate into healthier cash generation: operating cash flow fell to-$509K from-$263K in FY2023 even as the reported loss narrowed. Paired with another year of financing inflows and a much higher share count, that suggests earnings improved faster than cash reality and the business still relies on outside capital to cover operations.
With only
The loss engine sits in overhead, not production: FY2024 gross profit of
Financial Health Signals
We are recalculating Us Nuclear's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Us Nuclear scores -15.77, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($2.3M) relative to total liabilities ($2.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Us Nuclear passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Us Nuclear generates $0.16 in operating cash flow (-$199K OCF vs -$1.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Us Nuclear earns $-5.8 in operating income for every $1 of interest expense (-$939K vs $162K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Us Nuclear generated $2.2M in revenue in fiscal year 2025. This represents a decrease of 1.0% from the prior year.
Us Nuclear's EBITDA was -$938K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 38.8% from the prior year.
Us Nuclear reported -$1.2M in net income in fiscal year 2025. This represents an increase of 28.8% from the prior year.
Us Nuclear earned $-0.02 per diluted share (EPS) in fiscal year 2025. This represents an increase of 50.0% from the prior year.
Cash & Balance Sheet
Us Nuclear held $135K in cash against $532K in long-term debt as of fiscal year 2025.
Us Nuclear had 61M shares outstanding in fiscal year 2025. This represents an increase of 19.5% from the prior year.
Margins & Returns
Us Nuclear's gross margin was 50.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 3.9 percentage points from the prior year.
Us Nuclear's operating margin was -43.3% in fiscal year 2025, reflecting core business profitability. This is up 26.8 percentage points from the prior year.
Us Nuclear's net profit margin was -57.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 22.3 percentage points from the prior year.
Capital Allocation
Us Nuclear spent $7K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
UCLE Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $650K+9.2% | $595K+33.2% | $447K-6.2% | $477K+6.1% | $449K-26.5% | $611K+21.5% | $503K-19.9% | $628K |
| Cost of Revenue | $457K+54.3% | $296K+49.8% | $198K+54.7% | $128K-75.3% | $518K+274.8% | $138K-43.3% | $244K-10.9% | $274K |
| Gross Profit | $193K-35.5% | $299K+20.0% | $249K-28.5% | $349K+604.7% | -$69K-114.6% | $473K+82.8% | $258K-26.9% | $354K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | -$787K-241.1% | $558K+37.5% | $405K-53.5% | $873K+107519.9% | $811-99.9% | $542K-12.9% | $622K+24.8% | $498K |
| Operating Income | -$1K+99.6% | -$258K-65.5% | -$156K+70.2% | -$524K+45.3% | -$958K-1285.2% | -$69K+81.0% | -$363K-151.5% | -$144K |
| Interest Expense | $29K-58.3% | $69K+150.3% | $28K-23.9% | $36K-33.2% | $54K+30.3% | $42K-54.7% | $92K+147.7% | $37K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$618K-519.6% | $147K+170.9% | -$208K+62.9% | -$560K+44.6% | -$1.0M-812.0% | -$111K+75.6% | -$455K-181.2% | -$162K |
| EPS (Diluted) | N/A | $0.00+100.0% | $-0.010.0% | $-0.01 | N/A | $0.00+100.0% | $-0.01 | $0.00 |
UCLE Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9M-24.3% | $2.5M+1.3% | $2.5M+0.3% | $2.5M-5.6% | $2.6M-14.1% | $3.1M+8.4% | $2.8M-2.2% | $2.9M |
| Current Assets | $1.5M-24.7% | $2.0M+1.7% | $1.9M+0.4% | $1.9M-7.2% | $2.1M-17.4% | $2.5M+10.6% | $2.3M-2.7% | $2.3M |
| Cash & Equivalents | $135K+77.6% | $76K+64.0% | $46K-32.4% | $68K-47.7% | $131K+311.7% | $32K-76.9% | $138K+4.3% | $132K |
| Inventory | $1.1M-36.5% | $1.7M-5.5% | $1.8M+3.1% | $1.8M+13.9% | $1.5M-21.9% | $2.0M+8.7% | $1.8M+1.4% | $1.8M |
| Accounts Receivable | $214K+64.5% | $130K+237.2% | $39K-36.8% | $61K-82.6% | $351K-24.3% | $464K+65.9% | $280K-28.1% | $389K |
| Goodwill | $440K-22.9% | $570K0.0% | $570K0.0% | $570K0.0% | $570K0.0% | $570K0.0% | $570K0.0% | $570K |
| Total Liabilities | $2.4M+1.9% | $2.4M-26.6% | $3.3M+2.4% | $3.2M-9.2% | $3.5M+8.5% | $3.2M-37.4% | $5.2M+3.6% | $5.0M |
| Current Liabilities | $2.2M-2.7% | $2.2M-8.8% | $2.5M+3.2% | $2.4M-12.0% | $2.7M+11.8% | $2.4M-53.2% | $5.2M+3.6% | $5.0M |
| Long-Term Debt | $532K+53.2% | $347K-68.2% | $1.1M-8.5% | $1.2M-21.2% | $1.5M+136.7% | $638K-3.8% | $664K+0.6% | $660K |
| Total Equity | -$514K-450.9% | $146K+119.5% | -$751K-10.0% | -$683K+20.3% | -$856K-488.1% | -$146K+93.7% | -$2.3M-11.7% | -$2.1M |
| Retained Earnings | -$21.1M-3.3% | -$20.5M+0.5% | -$20.6M-1.2% | -$20.3M-3.2% | -$19.7M-5.8% | -$18.6M-0.6% | -$18.5M-2.5% | -$18.0M |
UCLE Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$103K-168.8% | $150K+197.7% | -$154K-66.1% | -$92K-10.7% | -$84K+64.6% | -$236K-135.4% | -$100K-13.4% | -$89K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | -$9K-162.5% | -$4K+75.2% | -$14K-257.7% | -$4K |
| Financing Cash Flow | $162K+234.6% | -$121K-191.7% | $131K+336.1% | $30K-84.3% | $192K+43.3% | $134K+11.3% | $120K+67.3% | $72K |
| Dividends Paid | $0+100.0% | -$96K-351.7% | $38K-56.3% | $87K | N/A | N/A | N/A | N/A |
| Share Buybacks | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A |
UCLE Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.7%-20.6pp | 50.2%-5.5pp | 55.8%-17.4pp | 73.2%+88.6pp | -15.4%-92.8pp | 77.4%+25.9pp | 51.4%-4.9pp | 56.4% |
| Operating Margin | -0.2%+43.2pp | -43.4%-8.5pp | -34.9%+75.0pp | -109.9%+103.4pp | -213.3%-202.0pp | -11.3%+60.9pp | -72.3%-49.3pp | -23.0% |
| Net Margin | -95.2%-119.9pp | 24.8%+71.2pp | -46.5%+71.0pp | -117.5%+107.7pp | -225.2%-207.0pp | -18.2%+72.5pp | -90.6%-64.8pp | -25.8% |
| Return on Equity | N/A | 100.7% | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -32.2%-38.0pp | 5.8%+14.1pp | -8.3%+14.1pp | -22.4%+15.8pp | -38.2%-34.6pp | -3.6%+12.4pp | -16.0%-10.4pp | -5.6% |
| Current Ratio | 0.68-0.2 | 0.88+0.1 | 0.79-0.0 | 0.81+0.0 | 0.77-0.3 | 1.04+0.6 | 0.44-0.0 | 0.47 |
| Debt-to-Equity | -1.03-3.4 | 2.37+3.8 | -1.45+0.3 | -1.74+0.0 | -1.77+2.6 | -4.39-4.1 | -0.29+0.0 | -0.32 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$514K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.68), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Us Nuclear's annual revenue?
Us Nuclear (UCLE) reported $2.2M in total revenue for fiscal year 2025. This represents a -1.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Us Nuclear's revenue growing?
Us Nuclear (UCLE) revenue declined by 1% year-over-year, from $2.2M to $2.2M in fiscal year 2025.
Is Us Nuclear profitable?
No, Us Nuclear (UCLE) reported a net income of -$1.2M in fiscal year 2025, with a net profit margin of -57.1%.
What is Us Nuclear's EBITDA?
Us Nuclear (UCLE) had EBITDA of -$938K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Us Nuclear have?
As of fiscal year 2025, Us Nuclear (UCLE) had $135K in cash and equivalents against $532K in long-term debt.
What is Us Nuclear's gross margin?
Us Nuclear (UCLE) had a gross margin of 50.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Us Nuclear's operating margin?
Us Nuclear (UCLE) had an operating margin of -43.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Us Nuclear's net profit margin?
Us Nuclear (UCLE) had a net profit margin of -57.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Us Nuclear's operating cash flow?
Us Nuclear (UCLE) generated -$199K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Us Nuclear's total assets?
Us Nuclear (UCLE) had $1.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Us Nuclear's current ratio?
Us Nuclear (UCLE) had a current ratio of 0.68 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Us Nuclear's debt-to-equity ratio?
Us Nuclear (UCLE) had a debt-to-equity ratio of -1.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Us Nuclear's return on assets (ROA)?
Us Nuclear (UCLE) had a return on assets of -64.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Us Nuclear's cash runway?
Based on fiscal year 2025 data, Us Nuclear (UCLE) had $135K in cash against an annual operating cash burn of $199K. This gives an estimated cash runway of approximately 8 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Us Nuclear's debt-to-equity ratio negative or unusual?
Us Nuclear (UCLE) has negative shareholder equity of -$514K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Us Nuclear's Altman Z-Score?
Us Nuclear (UCLE) has an Altman Z-Score of -15.77, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Us Nuclear's Piotroski F-Score?
Us Nuclear (UCLE) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Us Nuclear's earnings high quality?
Us Nuclear (UCLE) has an earnings quality ratio of 0.16x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Us Nuclear cover its interest payments?
Us Nuclear (UCLE) has an interest coverage ratio of -5.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.